$ 1.125 billion
Completed
5/8/2015
Rani Mehta - Journalist
United States
High-yield bond/note issue
Capital markets : Debt
Pharmaceuticals and life sciences
Party: JP Morgan Securities (Initial purchaser)
Party: Credit Suisse Securities (Initial purchaser)
Party: Goldman Sachs (Initial purchaser)
Party: UBS Securities (Initial purchaser)
Party: Deutsche Bank Securities (Initial purchaser)
Party: Morgan Stanley & Co (Initial purchaser)
Party: Barclays Capital (Initial purchaser)
Lawyers: Arthur Robinson, Ryan Bekkerus